Rhenman & Partners Asset Management Ab Keryx Biopharmaceuticals Inc Transaction History

Rhenman & Partners Asset Management Ab

  • $959 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 20, 2018
SELL
N/A
-302,157 Closed
0 $0
Q4 2017

Jan 19, 2018
SELL
N/A
-97,843 Reduced 24.46%
302,157 $1.41 Million
Q3 2017

Oct 13, 2017
BUY
N/A
400,000
400,000 $2.84 Million
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email